Apellis Receives Negative CHMP Opinion for Pegcetacoplan for Geographic[...]
09/27/2021 | Press release | Distributed by Public on 09/27/2021 04:05
Please select the service you want to use:
Smartlinks | Lazard Ltd. | News | Health | Healthcare Policy | Politics and Policy | Healthcare Policy | Policy and Regulation | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Jobs and Labor | Labor Policy and Legislation | Company News | Financial Services | Investment Services | Public Companies | Investment Companies | London Stock Exchange (LSE) | New York Stock Exchange (NYSE) | BX Swiss | Tradegate Exchange | NYSE American | NYSE ARCA Equities | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | Nasdaq Intermarket | Investors Exchange (IEX) | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact